Single Cell Sequencing Market by Product (Reagents & Kits, Platforms, Software), Workflow (Presequencing), Service (Sample Preparation, Bioinformatics), Sequencing (scRNA, scDNA), Application (Research, Diagnostic), End User - Global Forecast to 2030
The single-cell sequencing market is expected to reach USD 3.46 billion in 2030 from USD 1.95 billion in 2025, at a CAGR of 12.2% during the forecast period. The growth of this market can be attributed to ongoing technological advancements in single-cell sequencing technologies, which are becoming more accurate, scalable, and efficient. For instance, in July 2025, researchers from the Huazhong University of Science and Technology developed the Toti-N-Seq platform to overcome challenges in sample multiplexing and rare cell detection by using a special glycan-binding protein to label all types of cells and nuclei. At the same time, well-established systems like 10x Genomics’ Chromium remain essential for extensive studies due to their reliability, high throughput, and broad adoption.
“By type, the sequencing instruments segment is expected to register the highest growth rate during the forecast period.”
By type, the single-cell sequencing products market is segmented into consumables, instruments, and software. The instruments segment is further segmented into pre-sequencing and sequencing instruments. The sequencing instruments segment registered the highest CAGR during the forecast period. This growth is primarily driven by the emergence of new sequencing technology providers, such as Pacific Biosciences (PacBio), Oxford Nanopore Technologies, Element Biosciences, and Ultima Genomics, that have introduced platforms compatible with various single-cell sequencing workflows. Additionally, sequencing instruments remain the core technological driver of single-cell sequencing, performing the essential function of decoding nucleic acids at single-cell resolution. As applications of single-cell sequencing expand into areas like oncology, immunology, neuroscience, and microbiome studies, there is a corresponding rise in demand for sequencing instruments capable of handling increasingly complex, large-scale datasets.
“By service type, the sequencing services segment accounted for the largest share of the market in 2024.”
Based on service type, the single-cell sequencing market is pre-sequencing services, sequencing services, and data analysis & bioinformatic services. In 2024, the sequencing services segment held the largest share of the single-cell sequencing market by service type. The large share of this service segment can be attributed to the high cost and operational complexity of sequencing instruments. The growing demand for clinical-grade sequencing, higher throughput, and standardized data output has also driven the expansion of professional sequencing services, reinforcing their leading position in the market. Moreover, with the rising adoption of single-cell technologies in translational research and clinical studies, sequencing services offer a scalable and compliant solution for handling large sample volumes.
“The Asia Pacific region is expected to grow at the highest CAGR in the single-cell sequencing market during the forecast period.”
The market is segmented by region into North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. The Asia Pacific region is projected to register the highest CAGR in the single-cell sequencing market during the forecast period. The key factors driving the market growth include expanding biomedical research infrastructure, rising government funding, and increasing adoption of single-cell technologies in clinical and academic settings. Countries like China, Japan, and South Korea actively invest in genomics through national initiatives and grants. At the same time, companies such as Singleron Biotechnologies and Macrogen make the technology more accessible across research and diagnostic markets. The region’s large and genetically diverse populations offer vast opportunities for disease-specific single-cell studies, particularly in oncology and infectious diseases. Additionally, lower operational costs and growing outsourcing of sequencing services to Asia-based CROs further accelerate regional growth, making the Asia Pacific a key engine of expansion for the global single-cell sequencing market.
The primary interviews conducted for this report can be categorized as follows:
The study includes an in-depth competitive analysis of these key players in the single-cell sequencing market, with their company profiles, recent developments, and key market strategies.
Research Coverage:
This research report categorizes the single cell sequencing market by offering (products, services), by product type (consumables [pre-sequencing, sequencing], instruments [pre-sequencing instruments {microfluidics, PCR, LCM, FACs, others}, sequencing platforms], software), by product workflow (pre-sequencing, sequencing, software), by product end user (hospitals & diagnostic laboratories, academic & research institutes, pharmaceutical & biotechnology companies, contract research organizations), by service type (pre-sequencing services [sample preparation, library preparation], sequencing services, bioinformatics services), by service end users (hospitals & diagnostic laboratories, academic & research institutes, pharmaceutical & biotechnology companies), by sequencing type (single cell transciptome sequencing, single cell genome sequencing, single cell ATAC sequencing, others), by application (research application [basic & translation research {cancer research, stem cell & developmental biology, neurology & brain research, microbiology & infectious disease, organ development & regenerative medicine}, drug discovery & development], diagnostic & clinical application), by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa).
The report provides in-depth information on significant factors influencing the growth of the single-cell sequencing market, including drivers, trends, challenges, and opportunities. A thorough analysis of major industry players has been undertaken to provide insights into their business profiles, products/services, key strategies, collaborations, partnerships, and agreements. Additionally, the report encompasses recent developments such as new product launches and acquisitions within the single-cell sequencing market.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing the closest approximations of the revenue numbers for the overall single-cell sequencing market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business better and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights into the following pointers:
“By type, the sequencing instruments segment is expected to register the highest growth rate during the forecast period.”
By type, the single-cell sequencing products market is segmented into consumables, instruments, and software. The instruments segment is further segmented into pre-sequencing and sequencing instruments. The sequencing instruments segment registered the highest CAGR during the forecast period. This growth is primarily driven by the emergence of new sequencing technology providers, such as Pacific Biosciences (PacBio), Oxford Nanopore Technologies, Element Biosciences, and Ultima Genomics, that have introduced platforms compatible with various single-cell sequencing workflows. Additionally, sequencing instruments remain the core technological driver of single-cell sequencing, performing the essential function of decoding nucleic acids at single-cell resolution. As applications of single-cell sequencing expand into areas like oncology, immunology, neuroscience, and microbiome studies, there is a corresponding rise in demand for sequencing instruments capable of handling increasingly complex, large-scale datasets.
“By service type, the sequencing services segment accounted for the largest share of the market in 2024.”
Based on service type, the single-cell sequencing market is pre-sequencing services, sequencing services, and data analysis & bioinformatic services. In 2024, the sequencing services segment held the largest share of the single-cell sequencing market by service type. The large share of this service segment can be attributed to the high cost and operational complexity of sequencing instruments. The growing demand for clinical-grade sequencing, higher throughput, and standardized data output has also driven the expansion of professional sequencing services, reinforcing their leading position in the market. Moreover, with the rising adoption of single-cell technologies in translational research and clinical studies, sequencing services offer a scalable and compliant solution for handling large sample volumes.
“The Asia Pacific region is expected to grow at the highest CAGR in the single-cell sequencing market during the forecast period.”
The market is segmented by region into North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. The Asia Pacific region is projected to register the highest CAGR in the single-cell sequencing market during the forecast period. The key factors driving the market growth include expanding biomedical research infrastructure, rising government funding, and increasing adoption of single-cell technologies in clinical and academic settings. Countries like China, Japan, and South Korea actively invest in genomics through national initiatives and grants. At the same time, companies such as Singleron Biotechnologies and Macrogen make the technology more accessible across research and diagnostic markets. The region’s large and genetically diverse populations offer vast opportunities for disease-specific single-cell studies, particularly in oncology and infectious diseases. Additionally, lower operational costs and growing outsourcing of sequencing services to Asia-based CROs further accelerate regional growth, making the Asia Pacific a key engine of expansion for the global single-cell sequencing market.
The primary interviews conducted for this report can be categorized as follows:
- By Company Type: Tier 1- 44%, Tier 2- 32%, and Tier 3- 24%
- By Designation: (Managers)- 45%, (CXOs, Directors)- 30%, and (Executives)- 25%
- By Region: North America- 40%, Europe- 25%, Asia Pacific- 20%, and the Rest of the World- 15%
The study includes an in-depth competitive analysis of these key players in the single-cell sequencing market, with their company profiles, recent developments, and key market strategies.
Research Coverage:
This research report categorizes the single cell sequencing market by offering (products, services), by product type (consumables [pre-sequencing, sequencing], instruments [pre-sequencing instruments {microfluidics, PCR, LCM, FACs, others}, sequencing platforms], software), by product workflow (pre-sequencing, sequencing, software), by product end user (hospitals & diagnostic laboratories, academic & research institutes, pharmaceutical & biotechnology companies, contract research organizations), by service type (pre-sequencing services [sample preparation, library preparation], sequencing services, bioinformatics services), by service end users (hospitals & diagnostic laboratories, academic & research institutes, pharmaceutical & biotechnology companies), by sequencing type (single cell transciptome sequencing, single cell genome sequencing, single cell ATAC sequencing, others), by application (research application [basic & translation research {cancer research, stem cell & developmental biology, neurology & brain research, microbiology & infectious disease, organ development & regenerative medicine}, drug discovery & development], diagnostic & clinical application), by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa).
The report provides in-depth information on significant factors influencing the growth of the single-cell sequencing market, including drivers, trends, challenges, and opportunities. A thorough analysis of major industry players has been undertaken to provide insights into their business profiles, products/services, key strategies, collaborations, partnerships, and agreements. Additionally, the report encompasses recent developments such as new product launches and acquisitions within the single-cell sequencing market.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing the closest approximations of the revenue numbers for the overall single-cell sequencing market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business better and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights into the following pointers:
- Analysis of key drivers (Advancements in Single-Cell sequencing technologies, Growing Demand for Personalized Medicine and Biomarker Discovery, Integration of AI and ML in data analysis, Advantages over bulk sequencing), restraints (High cost of single cell sequencing and analysis products), opportunities (Development of Sequencing by Expansion (SBX) technology, Growing clinical applications), and challenges (Data Complexities and Analysis Bottleneck) influencing the growth of the market.
- Product Development/Innovation: Detailed insights on newly launched products/services of the single-cell sequencing market
- Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
- Market Diversification: Exhaustive information about new products/services, untapped geographies, recent developments, and investments in the single-cell sequencing market
- Competitive Assessment: In-depth assessment of market share, growth strategies and service offerings of leading players like 10x Genomics (US), Illumina Inc. (US), BD (US), Danaher (US), Thermo Fisher Scientific Inc. (US), Qiagen (Netherlands), and Pacbio (US) among others, in the single-cell sequencing market.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS & REGIONS COVERED
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 MARKET STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
2.2 MARKET ESTIMATION METHODOLOGY
2.2.1 MARKET SIZE ESTIMATION
2.2.2 SEGMENTAL MARKET ASSESSMENT
2.3 MARKET GROWTH RATE PROJECTIONS
2.4 DATA TRIANGULATION
2.5 RESEARCH ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.7 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
3.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
3.2 STRATEGIC IMPERATIVES FOR STAKEHOLDERS
3.3 DISRUPTIVE TRENDS SHAPING MARKET
4 PREMIUM INSIGHTS
4.1 SINGLE-CELL SEQUENCING MARKET SNAPSHOT
4.2 NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET, BY OFFERING & COUNTRY (2024)
4.3 SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE (2024)
4.4 SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER (2024)
4.5 SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER (2024)
4.6 SINGLE-CELL SEQUENCING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Advancements in single-cell sequencing technologies
5.2.1.2 Growing focus on precision medicine and biomarker discovery
5.2.1.3 Integration of AI & ML in data analysis
5.2.1.4 Advantages over conventional bulk sequencing
5.2.2 RESTRAINTS
5.2.2.1 High cost of single-cell sequencing products & services
5.2.3 OPPORTUNITIES
5.2.3.1 Emergence of SBX technology
5.2.3.2 Integration of multi-omics technologies
5.2.3.3 Growth potential of emerging economies
5.2.4 CHALLENGES
5.2.4.1 Complexities associated with high-dimensional single-cell data
5.2.4.2 Biological variability and cell heterogeneity
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.4 VALUE CHAIN ANALYSIS
5.5 ECOSYSTEM ANALYSIS
5.5.1 EMERGING BUSINESS MODELS AND ECOSYSTEM SHIFT IN SINGLE-CELL SEQUENCING MARKET
5.6 TECHNOLOGY ANALYSIS
5.6.1 KEY TECHNOLOGIES
5.6.1.1 Microfluidics partitioning
5.6.1.2 NGS
5.6.1.3 PCR
5.6.1.4 Flow cytometry
5.6.2 COMPLEMENTARY TECHNOLOGIES
5.6.2.1 Magnetic-activated Cell Sorting (MACS)
5.6.2.2 Tissue dissociation systems
5.6.2.3 Combinatorial indexing
5.6.3 ADJACENT TECHNOLOGIES
5.6.3.1 Bulk RNA-seq
5.6.3.2 In situ hybridization (ISH)
5.7 PATENT ANALYSIS
5.7.1 PATENT METHODOLOGY
5.7.2 PATENTS APPLIED & GRANTED, 2014–2024
5.8 TRADE ANALYSIS
5.8.1 IMPORT DATA (HS CODE 9027)
5.8.2 EXPORT DATA (HS CODE 9027)
5.9 PORTER’S FIVE FORCES ANALYSIS
5.9.1 THREAT OF NEW ENTRANTS
5.9.2 THREAT OF SUBSTITUTES
5.9.3 BARGAINING POWER OF SUPPLIERS
5.9.4 BARGAINING POWER OF BUYERS
5.9.5 INTENSITY OF COMPETITIVE RIVALRY
5.10 TARIFF & REGULATORY LANDSCAPE
5.10.1 TARIFF DATA (HS CODE 9027)
5.10.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.10.3 REGULATORY FRAMEWORK
5.11 PRICING ANALYSIS
5.11.1 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYER, 2022 —2024
5.11.2 AVERAGE SELLING PRICE OF PRODUCTS, BY REGION, 2024
5.12 KEY CONFERENCES & EVENTS, 2025–2026
5.13 KEY STAKEHOLDERS & BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.13.2 ROLE OF STAKEHOLDERS IN BUYING PROCESS
5.13.3 BUYING CRITERIA
5.14 CUSTOMER LANDSCAPE
5.14.1 STRATEGIC ANALYSIS OF GROWTH OPPORTUNITIES
5.14.2 UNMET NEEDS & WHITE SPACES
5.15 INVESTMENT & FUNDING ACTIVITIES
5.16 IMPACT OF AI/GENERATIVE AI ON SINGLE-CELL SEQUENCING MARKET
5.16.1 AI-USE CASES
5.16.2 KEY COMPANIES IMPLEMENTING AI
5.16.3 FUTURE OF AI IN SINGLE-CELL SEQUENCING
5.17 TRUMP TARIFF IMPACT ON SINGLE-CELL SEQUENCING MARKET
5.17.1 INTRODUCTION
5.17.2 KEY TARIFF RATES
5.17.3 PRICE IMPACT ANALYSIS
5.17.4 KEY IMPACT ON VARIOUS REGIONS
5.17.4.1 US
5.17.4.2 Europe
5.17.4.3 Asia Pacific
5.17.4.4 Rest of the World
5.17.5 END-USE INDUSTRY IMPACT
5.17.5.1 Pharmaceutical & biotech companies
5.17.5.2 CROs
5.17.5.3 Academic & research institutes
5.17.5.4 Hospitals & clinical laboratories
6 SINGLE-CELL SEQUENCING MARKET, BY OFFERING
6.1 INTRODUCTION
6.2 PRODUCTS
6.2.1 RECURRING DEMAND FOR CONSUMABLES TO DRIVE MARKET
6.3 SERVICES
6.3.1 HIGH RELIANCE ON SERVICE PROVIDERS FOR SEQUENCING ACTIVITIES TO PROPEL MARKET
7 SINGLE-CELL SEQUENCING PRODUCT MARKET, BY TYPE
7.1 INTRODUCTION
7.2 CONSUMABLES
7.2.1 PRE-SEQUENCING REAGENTS & KITS
7.2.1.1 Ongoing product launches & upgrades to fuel uptake
7.2.2 SEQUENCING REAGENTS & KITS
7.2.2.1 Ability to provide high-throughput and high-fidelity nucleotide reading to boost demand
7.3 INSTRUMENTS
7.3.1 PRE-SEQUENCING INSTRUMENTS
7.3.1.1 Microfluidic instruments
7.3.1.1.1 Increasing demand for reproducible & low-input single-cell workflows to fuel uptake
7.3.1.2 Cell sorters
7.3.1.2.1 Provision of high-precision isolation of viable cells to boost demand
7.3.1.3 PCR instruments
7.3.1.3.1 High sensitivity & reproducibility features to fuel uptake
7.3.1.4 LCM instruments
7.3.1.4.1 Increasing use across applications requiring spatial resolution to support demand
7.3.1.5 Other pre-sequencing instruments
7.3.2 SEQUENCING PLATFORMS
7.3.2.1 Rising adoption across research applications to drive market
7.4 SOFTWARE
7.4.1 SOFTWARE TOOLS
7.4.1.1 Rising demand for accurate & scalable processing of sequencing data to support market growth
7.4.2 DATA STORAGE & MANAGEMENT SOFTWARE
7.4.2.1 Secure handling, archival, and retrieval of large volumes of data to support market growth
8 SINGLE-CELL SEQUENCING PRODUCT MARKET, BY WORKFLOW
8.1 INTRODUCTION
8.2 PRE-SEQUENCING WORKFLOW
8.2.1 ABILITY TO ENABLE HIGH-THROUGHPUT WORKFLOW IN CLINICAL & RESEARCH SETTINGS TO DRIVE MARKET
8.3 SEQUENCING WORKFLOW
8.3.1 DEMAND FOR MULTI-OMIC SEQUENCING PLATFORMS IN TRANSLATIONAL RESEARCH & ONCOLOGY TO PROPEL MARKET
8.4 DATA ANALYSIS & INTERPRETATION WORKFLOW
8.4.1 COMPLEXITY OF SINGLE-CELL DATASETS TO FUEL MARKET
9 SINGLE-CELL SEQUENCING PRODUCT MARKET, BY END USER
9.1 INTRODUCTION
9.2 ACADEMIC & RESEARCH INSTITUTES
9.2.1 RISING FOCUS ON LIFE SCIENCES RESEARCH SUPPORTED BY FAVORABLE GRANTS & FUNDS TO DRIVE MARKET
9.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.3.1 INCREASING DEMAND FOR DRUG DISCOVERY & DEVELOPMENT TO PROPEL MARKET
9.4 HOSPITALS & CLINICAL LABORATORIES
9.4.1 RISING INTEGRATION OF ADVANCED SEQUENCING TECHNOLOGIES INTO CLINICAL WORKFLOWS TO BOOST DEMAND
9.5 CONTRACT RESEARCH ORGANIZATIONS (CROS)
9.5.1 INCREASING RELIANCE ON OUTSOURCING R&D ACTIVITIES TO SUPPORT MARKET GROWTH
10 SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE
10.1 INTRODUCTION
10.2 PRE-SEQUENCING SERVICES
10.2.1 SAMPLE PREPARATION, SINGLE-CELL ISOLATION, AND ENRICHMENT SERVICES
10.2.1.1 Rising demand for high-resolution cell profiling services to fuel market
10.2.2 LIBRARY PREPARATION SERVICES
10.2.2.1 Adoption of single-cell applications to fuel market
10.3 SEQUENCING SERVICES
10.3.1 INCREASING DEMAND FOR SCALABLE & APPLICATION-SPECIFIC SEQUENCING OUTPUTS TO DRIVE MARKET
10.4 DATA ANALYSIS & BIOINFORMATICS SERVICES
10.4.1 INCREASING FOCUS ON CREATION OF END-TO-END ANALYSIS PIPELINES TO SUPPORT MARKET GROWTH
11 SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER
11.1 INTRODUCTION
11.2 ACADEMIC & RESEARCH INSTITUTES
11.2.1 EXECUTION OF COMPLEX & LARGE-SCALE CELLULAR STUDIES TO DRIVE MARKET
11.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
11.3.1 INTEGRATION OF HIGH-THROUGHPUT SINGLE-CELL PLATFORMS IN DRUG DISCOVERY ACTIVITIES TO PROPEL MARKET
11.4 HOSPITALS & CLINICAL LABORATORIES
11.4.1 INCREASING USE ACROSS ONCOLOGY DIAGNOSTICS TO SUPPORT MARKET GROWTH
12 SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE
12.1 INTRODUCTION
12.2 SINGLE-CELL TRANSCRIPTOME SEQUENCING (SCRNA-SEQ)
12.2.1 WIDE APPLICATIONS FOR GENE EXPRESSION STUDIES TO DRIVE MARKET
12.3 SINGLE-CELL GENOME SEQUENCING (SCDNA-SEQ)
12.3.1 ANALYSIS OF GENOMIC VARIATIONS WITH COMPLEX ADVANCEMENTS TO FUEL MARKET
12.4 SINGLE-CELL ATAC SEQUENCING (SCATAC-SEQ)
12.4.1 IDENTIFICATION OF OPEN DNA REGIONS TO SUPPORT MARKET GROWTH
12.5 OTHER SINGLE-CELL SEQUENCING TYPES
13 SINGLE-CELL SEQUENCING MARKET, BY APPLICATION
13.1 INTRODUCTION
13.2 RESEARCH APPLICATIONS
13.2.1 BASIC & TRANSLATION RESEARCH
13.2.1.1 Cancer research
13.2.1.1.1 Growing demand for oncology therapeutics to drive market
13.2.1.2 Stem cell & developmental biology
13.2.1.2.1 Mapping stem cell heterogeneity and lineage dynamics with high precision to boost demand
13.2.1.3 Neurology & brain research
13.2.1.3.1 Growing focus on psychiatric & neurodevelopmental disorder research to fuel market
13.2.1.4 Microbiology & infectious diseases
13.2.1.4.1 Precise profiling of immune responses & pathogen behavior to boost demand
13.2.1.5 Organ development & regenerative medicine
13.2.1.5.1 Growing focus on precision medicine to fuel uptake
13.2.2 DRUG DISCOVERY & DEVELOPMENT
13.2.2.1 Improved target validation and patient stratification using single-cell data to drive market
13.3 DIAGNOSTIC & CLINICAL APPLICATIONS
13.3.1 RISING UPTAKE IN MOLECULAR DIAGNOSTICS & PERSONALIZED MEDICINE TO SUPPORT MARKET GROWTH
14 SINGLE-CELL SEQUENCING MARKET, BY REGION
14.1 INTRODUCTION
14.2 NORTH AMERICA
14.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
14.2.2 US
14.2.2.1 Increasing R&D investments & funding to drive market
14.2.3 CANADA
14.2.3.1 High prevalence of hemophilia to propel market
14.3 EUROPE
14.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
14.3.2 GERMANY
14.3.2.1 Increasing awareness of advanced cell therapies to drive market
14.3.3 UK
14.3.3.1 Rising adoption of single-cell analysis products to boost demand
14.3.4 FRANCE
14.3.4.1 Favorable government funding investments for genomics to fuel market
14.3.5 ITALY
14.3.5.1 Growing focus on cell biology research to fuel uptake
14.3.6 SPAIN
14.3.6.1 Increasing number of biotechnology companies to drive market
14.3.7 REST OF EUROPE
14.4 ASIA PACIFIC
14.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
14.4.2 CHINA
14.4.2.1 Increasing incidence of infectious diseases to drive market
14.4.3 JAPAN
14.4.3.1 Growing demand for personalized medicine to drive market
14.4.4 INDIA
14.4.4.1 Expansion of activities in cell biology and biotech sectors to drive market
14.4.5 SOUTH KOREA
14.4.5.1 Increasing number of strategic alliances to boost market
14.4.6 AUSTRALIA
14.4.6.1 Rising establishment of life science companies to boost demand
14.4.7 REST OF ASIA PACIFIC
14.5 LATIN AMERICA
14.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
14.5.2 BRAZIL
14.5.2.1 Focus on advancements in manufacturing infrastructure for biopharmaceuticals to propel market
14.5.3 MEXICO
14.5.3.1 Favorable government support for advanced sequencing technologies to drive market
14.5.4 REST OF LATIN AMERICA
14.6 MIDDLE EAST
14.6.1 MACROECONOMIC OUTLOOK IN MIDDLE EAST
14.6.2 GCC COUNTRIES
14.6.2.1 Kingdom of Saudi Arabia (KSA)
14.6.2.1.1 Increasing healthcare expenditure to drive market
14.6.2.2 United Arab Emirates
14.6.2.2.1 Improvements in medical sector to fuel uptake
14.6.2.3 Other GCC Countries
14.6.3 REST OF MIDDLE EAST
14.7 AFRICA
14.7.1 RISING FOCUS ON DRUG DISCOVERY & DEVELOPMENT TO SUPPORT MARKET GROWTH
14.7.2 MACROECONOMIC OUTLOOK FOR AFRICA
15 COMPETITIVE LANDSCAPE
15.1 OVERVIEW
15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021–2025
15.3 REVENUE ANALYSIS, 2022–2024
15.4 MARKET SHARE ANALYSIS, 2024
15.5 COMPANY EVALUATION MATRIX: KEY PRODUCT PROVIDERS, 2024
15.5.1 STARS
15.5.2 EMERGING LEADERS
15.5.3 PERVASIVE PLAYERS
15.5.4 PARTICIPANTS
15.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
15.5.5.1 Company footprint
15.5.5.2 Region footprint
15.5.5.3 Product type footprint
15.5.5.4 Workflow footprint
15.5.5.5 Application footprint
15.6 COMPANY EVALUATION MATRIX: KEY SERVICE PROVIDERS, 2024
15.6.1 STARS
15.6.2 EMERGING LEADERS
15.6.3 PERVASIVE PLAYERS
15.6.4 PARTICIPANTS
15.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
15.6.5.1 Company footprint
15.6.5.2 Region footprint
15.6.5.3 Service footprint
15.6.5.4 Application footprint
15.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
15.7.1 PROGRESSIVE COMPANIES
15.7.2 RESPONSIVE COMPANIES
15.7.3 DYNAMIC COMPANIES
15.7.4 STARTING BLOCKS
15.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
15.7.5.1 Detailed list of key startups/SMEs
15.7.5.2 Competitive benchmarking of key startups/SMEs
15.8 COMPANY VALUATION & FINANCIAL METRICS
15.8.1 FINANCIAL METRICS
15.8.2 COMPANY VALUATION
15.9 BRAND/PRODUCT COMPARISON
15.9.1 BRAND/PRODUCT COMPARATIVE ANALYSIS
15.10 COMPETITIVE SCENARIO
15.10.1 PRODUCT & SERVICE LAUNCHES
15.10.2 DEALS
16 COMPANY PROFILES
16.1 INTRODUCTION
16.2 KEY PRODUCT PROVIDERS
16.2.1 BECTON, DICKINSON AND COMPANY (BD)
16.2.1.1 Business overview
16.2.1.2 Products offered
16.2.1.3 Recent developments
16.2.1.3.1 Product launches
16.2.1.3.2 Deals
16.2.1.4 MnM view
16.2.1.4.1 Key strengths
16.2.1.4.2 Strategic choices
16.2.1.4.3 Weaknesses & competitive threats
16.2.2 THERMO FISHER SCIENTIFIC INC.
16.2.2.1 Business overview
16.2.2.2 Products offered
16.2.2.3 Recent developments
16.2.2.3.1 Product launches
16.2.2.4 MnM view
16.2.2.4.1 Key strengths
16.2.2.4.2 Strategic choices
16.2.2.4.3 Weaknesses & competitive threats
16.2.3 DANAHER CORPORATION
16.2.3.1 Business overview
16.2.3.2 Products offered
16.2.3.3 Recent developments
16.2.3.3.1 Product launches
16.2.3.3.2 Deals
16.2.3.4 MnM view
16.2.3.4.1 Key strengths
16.2.3.4.2 Strategic choices
16.2.3.4.3 Weaknesses & competitive threats
16.2.4 10X GENOMICS
16.2.4.1 Business overview
16.2.4.2 Products offered
16.2.4.3 Recent developments
16.2.4.3.1 Product launches
16.2.4.3.2 Deals
16.2.4.4 MnM view
16.2.4.4.1 Key strengths
16.2.4.4.2 Strategic choices
16.2.4.4.3 Weaknesses & competitive threats
16.2.5 ILLUMINA, INC.
16.2.5.1 Business overview
16.2.5.2 Products offered
16.2.5.3 Recent developments
16.2.5.3.1 Product launches
16.2.5.3.2 Deals
16.2.5.4 MnM view
16.2.5.4.1 Key strengths
16.2.5.4.2 Strategic choices
16.2.5.4.3 Weaknesses & competitive threats
16.2.6 MERCK KGAA
16.2.6.1 Business overview
16.2.6.2 Products offered
16.2.7 QIAGEN N.V.
16.2.7.1 Business overview
16.2.7.2 Products offered
16.2.8 BIO-RAD LABORATORIES, INC.
16.2.8.1 Business overview
16.2.8.2 Products offered
16.2.8.3 Recent developments
16.2.8.3.1 Product launches
16.2.9 TECAN TRADING AG
16.2.9.1 Business overview
16.2.9.2 Products offered
16.2.9.3 Recent developments
16.2.9.3.1 Product launches
16.2.9.3.2 Deals
16.2.10 CYTEK BIOSCIENCES
16.2.10.1 Business overview
16.2.10.2 Products offered
16.2.10.3 Recent developments
16.2.10.3.1 Product launches
16.2.10.3.2 Deals
16.2.10.3.3 Expansions
16.2.11 TAKARA BIO INC.
16.2.11.1 Business overview
16.2.11.2 Products offered
16.2.11.3 Recent developments
16.2.11.3.1 Product launches
16.2.11.3.2 Deals
16.2.12 BIO-TECHNE
16.2.12.1 Business overview
16.2.12.2 Products offered
16.2.12.3 Recent developments
16.2.12.3.1 Deals
16.2.13 PACBIO
16.2.13.1 Business overview
16.2.13.2 Products offered
16.2.13.3 Recent developments
16.2.13.3.1 Product launches
16.3 KEY SERVICE PROVIDERS
16.3.1 AZENTA US INC.
16.3.1.1 Business overview
16.3.1.2 Services offered
16.3.2 NOVOGENE CO., LTD.
16.3.2.1 Business overview
16.3.2.2 Services Offered
16.3.2.3 Recent developments
16.3.2.3.1 Service launches
16.3.2.3.2 Expansions
16.3.3 IQVIA INC.
16.3.3.1 Business overview
16.3.3.2 Services offered
16.3.4 ALMAC GROUP
16.3.4.1 Business overview
16.3.4.2 Services offered
16.3.5 CEGAT GMBH
16.3.5.1 Business overview
16.3.5.2 Services offered
16.3.6 ACTIVE MOTIF
16.3.6.1 Business overview
16.3.6.2 Services offered
16.4 OTHER PRODUCT PROVIDERS
16.4.1 SINGLERON BIOTECHNOLOGIES
16.4.2 CELL MICROSYSTEMS
16.4.3 NANOCELLECT BIOMEDICAL
16.4.4 OXFORD NANOPORE TECHNOLOGIES PLC.
16.4.5 REVVITY
16.4.6 PARSE BIOSCIENCES
16.4.7 ULTIMA GENOMICS
16.4.8 MISSION BIO
16.5 OTHER SERVICE PROVIDERS
16.5.1 SINGLE CELL DISCOVERIES BV
16.5.2 ADMERA HEALTH
16.5.3 BGI
16.5.4 SIGNIOSBIO
16.5.5 MACROGEN CO., LTD.
16.5.6 LEXOGEN GMBH
16.5.7 DISCOVERY LIFE SCIENCES
16.5.8 CELLCARTA
16.5.9 SINGULOMICS CORPORATION
16.5.10 SEQMATIC LLC.
17 APPENDIX
17.1 DISCUSSION GUIDE
17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
17.3 CUSTOMIZATION OPTIONS
17.4 RELATED REPORTS
17.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS & REGIONS COVERED
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 MARKET STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
2.2 MARKET ESTIMATION METHODOLOGY
2.2.1 MARKET SIZE ESTIMATION
2.2.2 SEGMENTAL MARKET ASSESSMENT
2.3 MARKET GROWTH RATE PROJECTIONS
2.4 DATA TRIANGULATION
2.5 RESEARCH ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.7 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
3.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
3.2 STRATEGIC IMPERATIVES FOR STAKEHOLDERS
3.3 DISRUPTIVE TRENDS SHAPING MARKET
4 PREMIUM INSIGHTS
4.1 SINGLE-CELL SEQUENCING MARKET SNAPSHOT
4.2 NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET, BY OFFERING & COUNTRY (2024)
4.3 SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE (2024)
4.4 SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER (2024)
4.5 SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER (2024)
4.6 SINGLE-CELL SEQUENCING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Advancements in single-cell sequencing technologies
5.2.1.2 Growing focus on precision medicine and biomarker discovery
5.2.1.3 Integration of AI & ML in data analysis
5.2.1.4 Advantages over conventional bulk sequencing
5.2.2 RESTRAINTS
5.2.2.1 High cost of single-cell sequencing products & services
5.2.3 OPPORTUNITIES
5.2.3.1 Emergence of SBX technology
5.2.3.2 Integration of multi-omics technologies
5.2.3.3 Growth potential of emerging economies
5.2.4 CHALLENGES
5.2.4.1 Complexities associated with high-dimensional single-cell data
5.2.4.2 Biological variability and cell heterogeneity
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.4 VALUE CHAIN ANALYSIS
5.5 ECOSYSTEM ANALYSIS
5.5.1 EMERGING BUSINESS MODELS AND ECOSYSTEM SHIFT IN SINGLE-CELL SEQUENCING MARKET
5.6 TECHNOLOGY ANALYSIS
5.6.1 KEY TECHNOLOGIES
5.6.1.1 Microfluidics partitioning
5.6.1.2 NGS
5.6.1.3 PCR
5.6.1.4 Flow cytometry
5.6.2 COMPLEMENTARY TECHNOLOGIES
5.6.2.1 Magnetic-activated Cell Sorting (MACS)
5.6.2.2 Tissue dissociation systems
5.6.2.3 Combinatorial indexing
5.6.3 ADJACENT TECHNOLOGIES
5.6.3.1 Bulk RNA-seq
5.6.3.2 In situ hybridization (ISH)
5.7 PATENT ANALYSIS
5.7.1 PATENT METHODOLOGY
5.7.2 PATENTS APPLIED & GRANTED, 2014–2024
5.8 TRADE ANALYSIS
5.8.1 IMPORT DATA (HS CODE 9027)
5.8.2 EXPORT DATA (HS CODE 9027)
5.9 PORTER’S FIVE FORCES ANALYSIS
5.9.1 THREAT OF NEW ENTRANTS
5.9.2 THREAT OF SUBSTITUTES
5.9.3 BARGAINING POWER OF SUPPLIERS
5.9.4 BARGAINING POWER OF BUYERS
5.9.5 INTENSITY OF COMPETITIVE RIVALRY
5.10 TARIFF & REGULATORY LANDSCAPE
5.10.1 TARIFF DATA (HS CODE 9027)
5.10.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.10.3 REGULATORY FRAMEWORK
5.11 PRICING ANALYSIS
5.11.1 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYER, 2022 —2024
5.11.2 AVERAGE SELLING PRICE OF PRODUCTS, BY REGION, 2024
5.12 KEY CONFERENCES & EVENTS, 2025–2026
5.13 KEY STAKEHOLDERS & BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.13.2 ROLE OF STAKEHOLDERS IN BUYING PROCESS
5.13.3 BUYING CRITERIA
5.14 CUSTOMER LANDSCAPE
5.14.1 STRATEGIC ANALYSIS OF GROWTH OPPORTUNITIES
5.14.2 UNMET NEEDS & WHITE SPACES
5.15 INVESTMENT & FUNDING ACTIVITIES
5.16 IMPACT OF AI/GENERATIVE AI ON SINGLE-CELL SEQUENCING MARKET
5.16.1 AI-USE CASES
5.16.2 KEY COMPANIES IMPLEMENTING AI
5.16.3 FUTURE OF AI IN SINGLE-CELL SEQUENCING
5.17 TRUMP TARIFF IMPACT ON SINGLE-CELL SEQUENCING MARKET
5.17.1 INTRODUCTION
5.17.2 KEY TARIFF RATES
5.17.3 PRICE IMPACT ANALYSIS
5.17.4 KEY IMPACT ON VARIOUS REGIONS
5.17.4.1 US
5.17.4.2 Europe
5.17.4.3 Asia Pacific
5.17.4.4 Rest of the World
5.17.5 END-USE INDUSTRY IMPACT
5.17.5.1 Pharmaceutical & biotech companies
5.17.5.2 CROs
5.17.5.3 Academic & research institutes
5.17.5.4 Hospitals & clinical laboratories
6 SINGLE-CELL SEQUENCING MARKET, BY OFFERING
6.1 INTRODUCTION
6.2 PRODUCTS
6.2.1 RECURRING DEMAND FOR CONSUMABLES TO DRIVE MARKET
6.3 SERVICES
6.3.1 HIGH RELIANCE ON SERVICE PROVIDERS FOR SEQUENCING ACTIVITIES TO PROPEL MARKET
7 SINGLE-CELL SEQUENCING PRODUCT MARKET, BY TYPE
7.1 INTRODUCTION
7.2 CONSUMABLES
7.2.1 PRE-SEQUENCING REAGENTS & KITS
7.2.1.1 Ongoing product launches & upgrades to fuel uptake
7.2.2 SEQUENCING REAGENTS & KITS
7.2.2.1 Ability to provide high-throughput and high-fidelity nucleotide reading to boost demand
7.3 INSTRUMENTS
7.3.1 PRE-SEQUENCING INSTRUMENTS
7.3.1.1 Microfluidic instruments
7.3.1.1.1 Increasing demand for reproducible & low-input single-cell workflows to fuel uptake
7.3.1.2 Cell sorters
7.3.1.2.1 Provision of high-precision isolation of viable cells to boost demand
7.3.1.3 PCR instruments
7.3.1.3.1 High sensitivity & reproducibility features to fuel uptake
7.3.1.4 LCM instruments
7.3.1.4.1 Increasing use across applications requiring spatial resolution to support demand
7.3.1.5 Other pre-sequencing instruments
7.3.2 SEQUENCING PLATFORMS
7.3.2.1 Rising adoption across research applications to drive market
7.4 SOFTWARE
7.4.1 SOFTWARE TOOLS
7.4.1.1 Rising demand for accurate & scalable processing of sequencing data to support market growth
7.4.2 DATA STORAGE & MANAGEMENT SOFTWARE
7.4.2.1 Secure handling, archival, and retrieval of large volumes of data to support market growth
8 SINGLE-CELL SEQUENCING PRODUCT MARKET, BY WORKFLOW
8.1 INTRODUCTION
8.2 PRE-SEQUENCING WORKFLOW
8.2.1 ABILITY TO ENABLE HIGH-THROUGHPUT WORKFLOW IN CLINICAL & RESEARCH SETTINGS TO DRIVE MARKET
8.3 SEQUENCING WORKFLOW
8.3.1 DEMAND FOR MULTI-OMIC SEQUENCING PLATFORMS IN TRANSLATIONAL RESEARCH & ONCOLOGY TO PROPEL MARKET
8.4 DATA ANALYSIS & INTERPRETATION WORKFLOW
8.4.1 COMPLEXITY OF SINGLE-CELL DATASETS TO FUEL MARKET
9 SINGLE-CELL SEQUENCING PRODUCT MARKET, BY END USER
9.1 INTRODUCTION
9.2 ACADEMIC & RESEARCH INSTITUTES
9.2.1 RISING FOCUS ON LIFE SCIENCES RESEARCH SUPPORTED BY FAVORABLE GRANTS & FUNDS TO DRIVE MARKET
9.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.3.1 INCREASING DEMAND FOR DRUG DISCOVERY & DEVELOPMENT TO PROPEL MARKET
9.4 HOSPITALS & CLINICAL LABORATORIES
9.4.1 RISING INTEGRATION OF ADVANCED SEQUENCING TECHNOLOGIES INTO CLINICAL WORKFLOWS TO BOOST DEMAND
9.5 CONTRACT RESEARCH ORGANIZATIONS (CROS)
9.5.1 INCREASING RELIANCE ON OUTSOURCING R&D ACTIVITIES TO SUPPORT MARKET GROWTH
10 SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE
10.1 INTRODUCTION
10.2 PRE-SEQUENCING SERVICES
10.2.1 SAMPLE PREPARATION, SINGLE-CELL ISOLATION, AND ENRICHMENT SERVICES
10.2.1.1 Rising demand for high-resolution cell profiling services to fuel market
10.2.2 LIBRARY PREPARATION SERVICES
10.2.2.1 Adoption of single-cell applications to fuel market
10.3 SEQUENCING SERVICES
10.3.1 INCREASING DEMAND FOR SCALABLE & APPLICATION-SPECIFIC SEQUENCING OUTPUTS TO DRIVE MARKET
10.4 DATA ANALYSIS & BIOINFORMATICS SERVICES
10.4.1 INCREASING FOCUS ON CREATION OF END-TO-END ANALYSIS PIPELINES TO SUPPORT MARKET GROWTH
11 SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER
11.1 INTRODUCTION
11.2 ACADEMIC & RESEARCH INSTITUTES
11.2.1 EXECUTION OF COMPLEX & LARGE-SCALE CELLULAR STUDIES TO DRIVE MARKET
11.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
11.3.1 INTEGRATION OF HIGH-THROUGHPUT SINGLE-CELL PLATFORMS IN DRUG DISCOVERY ACTIVITIES TO PROPEL MARKET
11.4 HOSPITALS & CLINICAL LABORATORIES
11.4.1 INCREASING USE ACROSS ONCOLOGY DIAGNOSTICS TO SUPPORT MARKET GROWTH
12 SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE
12.1 INTRODUCTION
12.2 SINGLE-CELL TRANSCRIPTOME SEQUENCING (SCRNA-SEQ)
12.2.1 WIDE APPLICATIONS FOR GENE EXPRESSION STUDIES TO DRIVE MARKET
12.3 SINGLE-CELL GENOME SEQUENCING (SCDNA-SEQ)
12.3.1 ANALYSIS OF GENOMIC VARIATIONS WITH COMPLEX ADVANCEMENTS TO FUEL MARKET
12.4 SINGLE-CELL ATAC SEQUENCING (SCATAC-SEQ)
12.4.1 IDENTIFICATION OF OPEN DNA REGIONS TO SUPPORT MARKET GROWTH
12.5 OTHER SINGLE-CELL SEQUENCING TYPES
13 SINGLE-CELL SEQUENCING MARKET, BY APPLICATION
13.1 INTRODUCTION
13.2 RESEARCH APPLICATIONS
13.2.1 BASIC & TRANSLATION RESEARCH
13.2.1.1 Cancer research
13.2.1.1.1 Growing demand for oncology therapeutics to drive market
13.2.1.2 Stem cell & developmental biology
13.2.1.2.1 Mapping stem cell heterogeneity and lineage dynamics with high precision to boost demand
13.2.1.3 Neurology & brain research
13.2.1.3.1 Growing focus on psychiatric & neurodevelopmental disorder research to fuel market
13.2.1.4 Microbiology & infectious diseases
13.2.1.4.1 Precise profiling of immune responses & pathogen behavior to boost demand
13.2.1.5 Organ development & regenerative medicine
13.2.1.5.1 Growing focus on precision medicine to fuel uptake
13.2.2 DRUG DISCOVERY & DEVELOPMENT
13.2.2.1 Improved target validation and patient stratification using single-cell data to drive market
13.3 DIAGNOSTIC & CLINICAL APPLICATIONS
13.3.1 RISING UPTAKE IN MOLECULAR DIAGNOSTICS & PERSONALIZED MEDICINE TO SUPPORT MARKET GROWTH
14 SINGLE-CELL SEQUENCING MARKET, BY REGION
14.1 INTRODUCTION
14.2 NORTH AMERICA
14.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
14.2.2 US
14.2.2.1 Increasing R&D investments & funding to drive market
14.2.3 CANADA
14.2.3.1 High prevalence of hemophilia to propel market
14.3 EUROPE
14.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
14.3.2 GERMANY
14.3.2.1 Increasing awareness of advanced cell therapies to drive market
14.3.3 UK
14.3.3.1 Rising adoption of single-cell analysis products to boost demand
14.3.4 FRANCE
14.3.4.1 Favorable government funding investments for genomics to fuel market
14.3.5 ITALY
14.3.5.1 Growing focus on cell biology research to fuel uptake
14.3.6 SPAIN
14.3.6.1 Increasing number of biotechnology companies to drive market
14.3.7 REST OF EUROPE
14.4 ASIA PACIFIC
14.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
14.4.2 CHINA
14.4.2.1 Increasing incidence of infectious diseases to drive market
14.4.3 JAPAN
14.4.3.1 Growing demand for personalized medicine to drive market
14.4.4 INDIA
14.4.4.1 Expansion of activities in cell biology and biotech sectors to drive market
14.4.5 SOUTH KOREA
14.4.5.1 Increasing number of strategic alliances to boost market
14.4.6 AUSTRALIA
14.4.6.1 Rising establishment of life science companies to boost demand
14.4.7 REST OF ASIA PACIFIC
14.5 LATIN AMERICA
14.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
14.5.2 BRAZIL
14.5.2.1 Focus on advancements in manufacturing infrastructure for biopharmaceuticals to propel market
14.5.3 MEXICO
14.5.3.1 Favorable government support for advanced sequencing technologies to drive market
14.5.4 REST OF LATIN AMERICA
14.6 MIDDLE EAST
14.6.1 MACROECONOMIC OUTLOOK IN MIDDLE EAST
14.6.2 GCC COUNTRIES
14.6.2.1 Kingdom of Saudi Arabia (KSA)
14.6.2.1.1 Increasing healthcare expenditure to drive market
14.6.2.2 United Arab Emirates
14.6.2.2.1 Improvements in medical sector to fuel uptake
14.6.2.3 Other GCC Countries
14.6.3 REST OF MIDDLE EAST
14.7 AFRICA
14.7.1 RISING FOCUS ON DRUG DISCOVERY & DEVELOPMENT TO SUPPORT MARKET GROWTH
14.7.2 MACROECONOMIC OUTLOOK FOR AFRICA
15 COMPETITIVE LANDSCAPE
15.1 OVERVIEW
15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021–2025
15.3 REVENUE ANALYSIS, 2022–2024
15.4 MARKET SHARE ANALYSIS, 2024
15.5 COMPANY EVALUATION MATRIX: KEY PRODUCT PROVIDERS, 2024
15.5.1 STARS
15.5.2 EMERGING LEADERS
15.5.3 PERVASIVE PLAYERS
15.5.4 PARTICIPANTS
15.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
15.5.5.1 Company footprint
15.5.5.2 Region footprint
15.5.5.3 Product type footprint
15.5.5.4 Workflow footprint
15.5.5.5 Application footprint
15.6 COMPANY EVALUATION MATRIX: KEY SERVICE PROVIDERS, 2024
15.6.1 STARS
15.6.2 EMERGING LEADERS
15.6.3 PERVASIVE PLAYERS
15.6.4 PARTICIPANTS
15.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
15.6.5.1 Company footprint
15.6.5.2 Region footprint
15.6.5.3 Service footprint
15.6.5.4 Application footprint
15.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
15.7.1 PROGRESSIVE COMPANIES
15.7.2 RESPONSIVE COMPANIES
15.7.3 DYNAMIC COMPANIES
15.7.4 STARTING BLOCKS
15.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
15.7.5.1 Detailed list of key startups/SMEs
15.7.5.2 Competitive benchmarking of key startups/SMEs
15.8 COMPANY VALUATION & FINANCIAL METRICS
15.8.1 FINANCIAL METRICS
15.8.2 COMPANY VALUATION
15.9 BRAND/PRODUCT COMPARISON
15.9.1 BRAND/PRODUCT COMPARATIVE ANALYSIS
15.10 COMPETITIVE SCENARIO
15.10.1 PRODUCT & SERVICE LAUNCHES
15.10.2 DEALS
16 COMPANY PROFILES
16.1 INTRODUCTION
16.2 KEY PRODUCT PROVIDERS
16.2.1 BECTON, DICKINSON AND COMPANY (BD)
16.2.1.1 Business overview
16.2.1.2 Products offered
16.2.1.3 Recent developments
16.2.1.3.1 Product launches
16.2.1.3.2 Deals
16.2.1.4 MnM view
16.2.1.4.1 Key strengths
16.2.1.4.2 Strategic choices
16.2.1.4.3 Weaknesses & competitive threats
16.2.2 THERMO FISHER SCIENTIFIC INC.
16.2.2.1 Business overview
16.2.2.2 Products offered
16.2.2.3 Recent developments
16.2.2.3.1 Product launches
16.2.2.4 MnM view
16.2.2.4.1 Key strengths
16.2.2.4.2 Strategic choices
16.2.2.4.3 Weaknesses & competitive threats
16.2.3 DANAHER CORPORATION
16.2.3.1 Business overview
16.2.3.2 Products offered
16.2.3.3 Recent developments
16.2.3.3.1 Product launches
16.2.3.3.2 Deals
16.2.3.4 MnM view
16.2.3.4.1 Key strengths
16.2.3.4.2 Strategic choices
16.2.3.4.3 Weaknesses & competitive threats
16.2.4 10X GENOMICS
16.2.4.1 Business overview
16.2.4.2 Products offered
16.2.4.3 Recent developments
16.2.4.3.1 Product launches
16.2.4.3.2 Deals
16.2.4.4 MnM view
16.2.4.4.1 Key strengths
16.2.4.4.2 Strategic choices
16.2.4.4.3 Weaknesses & competitive threats
16.2.5 ILLUMINA, INC.
16.2.5.1 Business overview
16.2.5.2 Products offered
16.2.5.3 Recent developments
16.2.5.3.1 Product launches
16.2.5.3.2 Deals
16.2.5.4 MnM view
16.2.5.4.1 Key strengths
16.2.5.4.2 Strategic choices
16.2.5.4.3 Weaknesses & competitive threats
16.2.6 MERCK KGAA
16.2.6.1 Business overview
16.2.6.2 Products offered
16.2.7 QIAGEN N.V.
16.2.7.1 Business overview
16.2.7.2 Products offered
16.2.8 BIO-RAD LABORATORIES, INC.
16.2.8.1 Business overview
16.2.8.2 Products offered
16.2.8.3 Recent developments
16.2.8.3.1 Product launches
16.2.9 TECAN TRADING AG
16.2.9.1 Business overview
16.2.9.2 Products offered
16.2.9.3 Recent developments
16.2.9.3.1 Product launches
16.2.9.3.2 Deals
16.2.10 CYTEK BIOSCIENCES
16.2.10.1 Business overview
16.2.10.2 Products offered
16.2.10.3 Recent developments
16.2.10.3.1 Product launches
16.2.10.3.2 Deals
16.2.10.3.3 Expansions
16.2.11 TAKARA BIO INC.
16.2.11.1 Business overview
16.2.11.2 Products offered
16.2.11.3 Recent developments
16.2.11.3.1 Product launches
16.2.11.3.2 Deals
16.2.12 BIO-TECHNE
16.2.12.1 Business overview
16.2.12.2 Products offered
16.2.12.3 Recent developments
16.2.12.3.1 Deals
16.2.13 PACBIO
16.2.13.1 Business overview
16.2.13.2 Products offered
16.2.13.3 Recent developments
16.2.13.3.1 Product launches
16.3 KEY SERVICE PROVIDERS
16.3.1 AZENTA US INC.
16.3.1.1 Business overview
16.3.1.2 Services offered
16.3.2 NOVOGENE CO., LTD.
16.3.2.1 Business overview
16.3.2.2 Services Offered
16.3.2.3 Recent developments
16.3.2.3.1 Service launches
16.3.2.3.2 Expansions
16.3.3 IQVIA INC.
16.3.3.1 Business overview
16.3.3.2 Services offered
16.3.4 ALMAC GROUP
16.3.4.1 Business overview
16.3.4.2 Services offered
16.3.5 CEGAT GMBH
16.3.5.1 Business overview
16.3.5.2 Services offered
16.3.6 ACTIVE MOTIF
16.3.6.1 Business overview
16.3.6.2 Services offered
16.4 OTHER PRODUCT PROVIDERS
16.4.1 SINGLERON BIOTECHNOLOGIES
16.4.2 CELL MICROSYSTEMS
16.4.3 NANOCELLECT BIOMEDICAL
16.4.4 OXFORD NANOPORE TECHNOLOGIES PLC.
16.4.5 REVVITY
16.4.6 PARSE BIOSCIENCES
16.4.7 ULTIMA GENOMICS
16.4.8 MISSION BIO
16.5 OTHER SERVICE PROVIDERS
16.5.1 SINGLE CELL DISCOVERIES BV
16.5.2 ADMERA HEALTH
16.5.3 BGI
16.5.4 SIGNIOSBIO
16.5.5 MACROGEN CO., LTD.
16.5.6 LEXOGEN GMBH
16.5.7 DISCOVERY LIFE SCIENCES
16.5.8 CELLCARTA
16.5.9 SINGULOMICS CORPORATION
16.5.10 SEQMATIC LLC.
17 APPENDIX
17.1 DISCUSSION GUIDE
17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
17.3 CUSTOMIZATION OPTIONS
17.4 RELATED REPORTS
17.5 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 SINGLE-CELL SEQUENCING MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
TABLE 3 SINGLE-CELL SEQUENCING MARKET: RISK ASSESSMENT ANALYSIS
TABLE 4 SINGLE-CELL SEQUENCING MARKET: IMPACT ANALYSIS
TABLE 5 SINGLE-CELL SEQUENCING MARKET: RAW MATERIAL VENDORS
TABLE 6 SINGLE-CELL SEQUENCING MARKET: EMERGING BUSINESS MODELS & STRATEGIC ADVANTAGE
TABLE 7 PATENTS APPLIED & GRANTED, 2014–2024
TABLE 8 INNOVATIONS & PATENT REGISTRATIONS, 2024
TABLE 9 IMPORT VALUE OF HS CODE 9027-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020–2024 (USD THOUSANDS)
TABLE 10 IMPORT VOLUME FOR HS CODE 9027-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020–2024 (TONS)
TABLE 11 EXPORT VALUE OF HS CODE 9027-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020–2024 (USD THOUSANDS)
TABLE 12 EXPORT VOLUME FOR HS CODE 9027-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020–2024 (TONS)
TABLE 13 SINGLE-CELL SEQUENCING MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 14 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 15 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18 SINGLE-CELL SEQUENCING MARKET: REGULATORY GUIDELINES
TABLE 19 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYER, 2022–2024
TABLE 20 AVERAGE SELLING PRICE OF PRODUCTS, BY REGION, 2024
TABLE 21 SINGLE-CELL SEQUENCING MARKET: KEY CONFERENCES & EVENTS, 2025–2026
TABLE 22 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR SINGLE-CELL SEQUENCING PRODUCTS
TABLE 23 BUYING CRITERIA FOR SINGLE-CELL SEQUENCING PRODUCTS, BY END USER
TABLE 24 SINGLE-CELL SEQUENCING MARKET: STRATEGIC ANALYSIS OF GROWTH OPPORTUNITIES
TABLE 25 KEY COMPANIES IMPLEMENTING AI IN SINGLE-CELL SEQUENCING MARKET
TABLE 26 KEY PRODUCT-RELATED TARIFF: MISCELLANEOUS CHEMICAL PRODUCTS, ELECTRICAL MACHINERY & EQUIPMENT, AND PARTS THEREOF.
TABLE 27 SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 28 SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 29 NORTH AMERICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 30 EUROPE: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 31 ASIA PACIFIC: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 32 LATIN AMERICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 33 MIDDLE EAST: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 34 GCC COUNTRIES: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 35 SINGLE-CELL SEQUENCING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 36 NORTH AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 37 EUROPE: SINGLE-CELL SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 38 ASIA PACIFIC: SINGLE-CELL SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 39 LATIN AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 40 MIDDLE EAST: SINGLE-CELL SEQUENCING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 41 GCC COUNTRIES: SINGLE-CELL SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 42 SINGLE-CELL SEQUENCING PRODUCT MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 43 SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 44 PRE-SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 45 NORTH AMERICA: PRE-SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 46 EUROPE: PRE-SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 47 ASIA PACIFIC: PRE-SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 48 LATIN AMERICA: PRE-SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 49 MIDDLE EAST: PRE-SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 50 GCC COUNTRIES: PRE-SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 51 SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 52 NORTH AMERICA: SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 53 EUROPE: SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 54 ASIA PACIFIC: SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 55 LATIN AMERICA: SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 56 MIDDLE EAST: SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 57 GCC COUNTRIES: SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 58 SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 59 PRE-SEQUENCING INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 60 NORTH AMERICA: PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 61 EUROPE: PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 62 ASIA PACIFIC: PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 63 LATIN AMERICA: PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 64 MIDDLE EAST: PRE-SEQUENCING INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 65 GCC COUNTRIES: PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 66 PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 67 MICROFLUIDIC INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 68 NORTH AMERICA: MICROFLUIDIC INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 69 EUROPE: MICROFLUIDIC INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 70 ASIA PACIFIC: MICROFLUIDIC INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 71 LATIN AMERICA: MICROFLUIDIC INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 72 MIDDLE EAST: MICROFLUIDIC INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 73 GCC COUNTRIES: MICROFLUIDIC INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 74 CELL SORTERS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 75 NORTH AMERICA: CELL SORTERS MARKET, 2023–2030 (USD MILLION)
TABLE 76 EUROPE: CELL SORTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 77 ASIA PACIFIC: CELL SORTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 78 LATIN AMERICA: CELL SORTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 79 MIDDLE EAST: CELL SORTERS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 80 GCC COUNTRIES: CELL SORTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 81 PCR INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 82 NORTH AMERICA: PCR INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 83 EUROPE: PCR INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 84 ASIA PACIFIC: PCR INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 85 LATIN AMERICA: PCR INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 86 MIDDLE EAST: PCR INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 87 GCC COUNTRIES: PCR INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 88 LCM INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 89 NORTH AMERICA: LCM INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 90 EUROPE: LCM INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 91 ASIA PACIFIC: LCM INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 92 LATIN AMERICA: LCM INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 93 MIDDLE EAST: LCM INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 94 GCC COUNTRIES: LCM INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 95 OTHER PRE-SEQUENCING INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 96 NORTH AMERICA: OTHER PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 97 EUROPE: OTHER PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 98 ASIA PACIFIC: OTHER PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 99 LATIN AMERICA: OTHER PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 100 MIDDLE EAST: OTHER PRE-SEQUENCING INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 101 GCC COUNTRIES: OTHER PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 102 SEQUENCING PLATFORMS MARKET, BY TYPE, 2023–2030 (UNITS)
TABLE 103 SEQUENCING PLATFORMS INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 104 NORTH AMERICA: SEQUENCING PLATFORMS INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 105 EUROPE: SEQUENCING PLATFORMS INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 106 ASIA PACIFIC: SEQUENCING PLATFORMS INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 107 LATIN AMERICA: SEQUENCING PLATFORMS INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 108 MIDDLE EAST: SEQUENCING PLATFORMS INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 109 GCC COUNTRIES: SEQUENCING PLATFORMS INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 110 SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 111 NORTH AMERICA: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 112 EUROPE: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 113 ASIA PACIFIC: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 114 LATIN AMERICA: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 115 MIDDLE EAST: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 116 GCC COUNTRIES: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 117 SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 118 SINGLE-CELL SEQUENCING SOFTWARE TOOLS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 119 NORTH AMERICA: SINGLE-CELL SEQUENCING SOFTWARE TOOLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 120 EUROPE: SINGLE-CELL SEQUENCING SOFTWARE TOOLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 121 ASIA PACIFIC: SINGLE-CELL SEQUENCING SOFTWARE TOOLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 122 LATIN AMERICA: SINGLE-CELL SEQUENCING SOFTWARE TOOLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 123 MIDDLE EAST: SINGLE-CELL SEQUENCING SOFTWARE TOOLS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 124 GCC COUNTRIES: SINGLE-CELL SEQUENCING SOFTWARE TOOLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 125 SINGLE-CELL SEQUENCING DATA STORAGE & MANAGEMENT SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 126 NORTH AMERICA: SINGLE-CELL SEQUENCING DATA STORAGE & MANAGEMENT SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 127 EUROPE: SINGLE-CELL SEQUENCING DATA STORAGE & MANAGEMENT SOFTWARE MARKET, 2023–2030 (USD MILLION)
TABLE 128 ASIA PACIFIC: SINGLE-CELL SEQUENCING DATA STORAGE & MANAGEMENT SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 129 LATIN AMERICA: SINGLE-CELL SEQUENCING DATA STORAGE & MANAGEMENT SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 130 MIDDLE EAST: SINGLE-CELL SEQUENCING DATA STORAGE & MANAGEMENT SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 131 GCC COUNTRIES: SINGLE-CELL SEQUENCING DATA STORAGE & MANAGEMENT SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 132 SINGLE-CELL SEQUENCING PRODUCT MARKET, BY WORKFLOW, 2023–2030 (USD MILLION)
TABLE 133 PRE-SEQUENCING PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 134 NORTH AMERICA: PRE-SEQUENCING PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 135 EUROPE: PRE-SEQUENCING PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 136 ASIA PACIFIC: PRE-SEQUENCING PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 137 LATIN AMERICA: PRE-SEQUENCING PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 138 MIDDLE EAST: PRE-SEQUENCING PRODUCT MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 139 GCC COUNTRIES: PRE-SEQUENCING PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 140 SEQUENCING PRODUCT MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 141 NORTH AMERICA: SEQUENCING PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 142 EUROPE: SEQUENCING PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 143 ASIA PACIFIC: SEQUENCING PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 144 LATIN AMERICA: SEQUENCING PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 145 MIDDLE EAST: SEQUENCING PRODUCT MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 146 GCC COUNTRIES: SEQUENCING PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 147 DATA ANALYSIS & INTERPRETATION PRODUCT MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 148 NORTH AMERICA: DATA ANALYSIS & INTERPRETATION PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 149 EUROPE: DATA ANALYSIS & INTERPRETATION PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 150 ASIA PACIFIC: DATA ANALYSIS & INTERPRETATION PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 151 LATIN AMERICA: DATA ANALYSIS & INTERPRETATION PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 152 MIDDLE EAST: DATA ANALYSIS & INTERPRETATION PRODUCT MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 153 GCC COUNTRIES: DATA ANALYSIS & INTERPRETATION PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 154 SINGLE-CELL SEQUENCING PRODUCT MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 155 SINGLE-CELL SEQUENCING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION)
TABLE 156 NORTH AMERICA: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 157 EUROPE: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 158 ASIA PACIFIC: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 159 LATIN AMERICA: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 160 MIDDLE EAST: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION)
TABLE 161 GCC COUNTRIES: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 162 SINGLE-CELL SEQUENCING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 163 NORTH AMERICA: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 164 EUROPE: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 165 ASIA PACIFIC: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 166 LATIN AMERICA: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 167 MIDDLE EAST: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 168 GCC COUNTRIES: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 169 SINGLE-CELL SEQUENCING PRODUCT MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 170 NORTH AMERICA: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 171 EUROPE: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 172 ASIA PACIFIC: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 173 LATIN AMERICA: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 174 MIDDLE EAST: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 175 GCC COUNTRIES: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 176 SINGLE-CELL SEQUENCING PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2023–2030 (USD MILLION)
TABLE 177 NORTH AMERICA: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 178 EUROPE: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 179 ASIA PACIFIC: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 180 LATIN AMERICA: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 181 MIDDLE EAST: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2023–2030 (USD MILLION)
TABLE 182 GCC COUNTRIES: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 183 SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 184 PRE-SEQUENCING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 185 NORTH AMERICA: PRE-SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 186 EUROPE: PRE-SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 187 ASIA PACIFIC: PRE-SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 188 LATIN AMERICA: PRE-SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 189 MIDDLE EAST: PRE-SEQUENCING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 190 GCC COUNTRIES: PRE-SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 191 PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 192 SAMPLE PREPARATION, SINGLE-CELL ISOLATION, AND ENRICHMENT SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 193 NORTH AMERICA: SAMPLE PREPARATION, SINGLE-CELL ISOLATION, AND ENRICHMENT SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 194 EUROPE: SAMPLE PREPARATION, SINGLE-CELL ISOLATION, AND ENRICHMENT SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 195 ASIA PACIFIC: SAMPLE PREPARATION, SINGLE-CELL ISOLATION, AND ENRICHMENT SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 196 LATIN AMERICA: SAMPLE PREPARATION, SINGLE-CELL ISOLATION, AND ENRICHMENT SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 197 MIDDLE EAST: SAMPLE PREPARATION, SINGLE-CELL ISOLATION, AND ENRICHMENT SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 198 GCC COUNTRIES: SAMPLE PREPARATION, SINGLE-CELL ISOLATION, AND ENRICHMENT SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 199 LIBRARY PREPARATION SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 200 NORTH AMERICA: LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 201 EUROPE: LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 202 ASIA PACIFIC: LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 203 LATIN AMERICA: LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 204 MIDDLE EAST: LIBRARY PREPARATION SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 205 GCC COUNTRIES: LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 206 SEQUENCING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 207 NORTH AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 208 EUROPE: SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 209 ASIA PACIFIC: SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 210 LATIN AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 211 MIDDLE EAST: SEQUENCING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 212 GCC COUNTRIES: SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 213 DATA ANALYSIS & BIOINFORMATICS SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 214 NORTH AMERICA: DATA ANALYSIS & BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 215 EUROPE: DATA ANALYSIS & BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 216 ASIA PACIFIC: DATA ANALYSIS & BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 217 LATIN AMERICA: DATA ANALYSIS & BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 218 MIDDLE EAST: DATA ANALYSIS & BIOINFORMATICS SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 219 GCC COUNTRIES: DATA ANALYSIS & BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 220 SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 221 SINGLE-CELL SEQUENCING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION)
TABLE 222 NORTH AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 223 EUROPE: SINGLE-CELL SEQUENCING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 224 ASIA PACIFIC: SINGLE-CELL SEQUENCING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 225 LATIN AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 226 MIDDLE EAST: SINGLE-CELL SEQUENCING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION)
TABLE 227 GCC COUNTRIES: SINGLE-CELL SEQUENCING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 228 SINGLE-CELL SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 229 NORTH AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 230 EUROPE: SINGLE-CELL SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 231 ASIA PACIFIC: SINGLE-CELL SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 232 LATIN AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 233 MIDDLE EAST: SINGLE-CELL SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 234 GCC COUNTRIES: SINGLE-CELL SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 235 SINGLE-CELL SEQUENCING SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 236 NORTH AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 237 EUROPE: SINGLE-CELL SEQUENCING SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 238 ASIA PACIFIC: SINGLE-CELL SEQUENCING SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 239 LATIN AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 240 MIDDLE EAST: SINGLE-CELL SEQUENCING SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 241 GCC COUNTRIES: SINGLE-CELL SEQUENCING SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 242 SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION)
TABLE 243 SINGLE-CELL TRANSCRIPTOME SEQUENCING MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 244 NORTH AMERICA: SINGLE-CELL TRANSCRIPTOME SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 245 EUROPE: SINGLE-CELL TRANSCRIPTOME SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 246 ASIA PACIFIC: SINGLE-CELL TRANSCRIPTOME SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 247 LATIN AMERICA: SINGLE-CELL TRANSCRIPTOME SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 248 MIDDLE EAST: SINGLE-CELL TRANSCRIPTOME SEQUENCING MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 249 GCC COUNTRIES: SINGLE-CELL TRANSCRIPTOME SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 250 SINGLE-CELL GENOME SEQUENCING MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 251 NORTH AMERICA: SINGLE-CELL GENOME SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 252 EUROPE: SINGLE-CELL GENOME SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 253 ASIA PACIFIC: SINGLE-CELL GENOME SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 254 LATIN AMERICA: SINGLE-CELL GENOME SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 255 MIDDLE EAST: SINGLE-CELL GENOME SEQUENCING MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 256 GCC COUNTRIES: SINGLE-CELL GENOME SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 257 SINGLE-CELL ATAC SEQUENCING MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 258 NORTH AMERICA: SINGLE-CELL ATAC SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 259 EUROPE: SINGLE-CELL ATAC SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 260 ASIA PACIFIC: SINGLE-CELL ATAC SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 261 LATIN AMERICA: SINGLE-CELL ATAC SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 262 MIDDLE EAST: SINGLE-CELL ATAC SEQUENCING MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 263 GCC COUNTRIES: SINGLE-CELL ATAC SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 264 OTHER SINGLE-CELL SEQUENCING TYPES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 265 NORTH AMERICA: OTHER SINGLE-CELL SEQUENCING TYPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 266 EUROPE: OTHER SINGLE-CELL SEQUENCING TYPES MARKET, 2023–2030 (USD MILLION)
TABLE 267 ASIA PACIFIC: OTHER SINGLE-CELL SEQUENCING TYPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 268 LATIN AMERICA: OTHER SINGLE-CELL SEQUENCING TYPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 269 MIDDLE EAST: OTHER SINGLE-CELL SEQUENCING TYPES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 270 GCC COUNTRIES: OTHER SINGLE-CELL SEQUENCING TYPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 271 SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 272 SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 273 SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATIONAL RESEARCH, BY TYPE, 2023–2030 (USD MILLION)
TABLE 274 SINGLE-CELL SEQUENCING MARKET FOR CANCER RESEARCH, BY REGION, 2023–2030 (USD MILLION)
TABLE 275 NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 276 EUROPE: SINGLE-CELL SEQUENCING MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 277 ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 278 LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 279 MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR CANCER RESEARCH, BY REGION, 2023–2030 (USD MILLION)
TABLE 280 GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 281 SINGLE-CELL SEQUENCING MARKET FOR STEM CELL & DEVELOPMENTAL BIOLOGY, BY REGION, 2023–2030 (USD MILLION)
TABLE 282 NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET FOR STEM CELL & DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 283 EUROPE: SINGLE-CELL SEQUENCING MARKET FOR STEM CELL & DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 284 ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR STEM CELL & DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 285 LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR STEM CELL & DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 286 MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR STEM CELL & DEVELOPMENTAL BIOLOGY, BY REGION, 2023–2030 (USD MILLION)
TABLE 287 GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR STEM CELL & DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 288 SINGLE-CELL SEQUENCING MARKET FOR NEUROLOGY & BRAIN RESEARCH, BY REGION, 2023–2030 (USD MILLION)
TABLE 289 NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET FOR NEUROLOGY & BRAIN RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 290 EUROPE: SINGLE-CELL SEQUENCING MARKET FOR NEUROLOGY & BRAIN RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 291 ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR NEUROLOGY & BRAIN RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 292 LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR NEUROLOGY & BRAIN RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 293 MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR NEUROLOGY & BRAIN RESEARCH, BY REGION, 2023–2030 (USD MILLION)
TABLE 294 GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR NEUROLOGY & BRAIN RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 295 SINGLE-CELL SEQUENCING MARKET FOR MICROBIOLOGY & INFECTIOUS DISEASES, BY REGION, 2023–2030 (USD MILLION)
TABLE 296 NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET FOR MICROBIOLOGY & INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 297 EUROPE: SINGLE-CELL SEQUENCING MARKET FOR MICROBIOLOGY & INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 298 ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR MICROBIOLOGY & INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 299 LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR MICROBIOLOGY & INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 300 MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR MICROBIOLOGY & INFECTIOUS DISEASES, BY REGION, 2023–2030 (USD MILLION)
TABLE 301 GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR MICROBIOLOGY & INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 302 SINGLE-CELL SEQUENCING MARKET FOR ORGAN DEVELOPMENT & REGENERATIVE MEDICINE, BY REGION, 2023–2030 (USD MILLION)
TABLE 303 NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET FOR ORGAN DEVELOPMENT & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 304 EUROPE: SINGLE-CELL SEQUENCING MARKET FOR ORGAN DEVELOPMENT & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 305 ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR ORGAN DEVELOPMENT & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 306 LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR ORGAN DEVELOPMENT & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 307 MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR ORGAN DEVELOPMENT & REGENERATIVE MEDICINE, BY REGION, 2023–2030 (USD MILLION)
TABLE 308 GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR ORGAN DEVELOPMENT & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 309 SINGLE-CELL SEQUENCING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2023–2030 (USD MILLION)
TABLE 310 NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 311 EUROPE: SINGLE-CELL SEQUENCING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 312 ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 313 LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 314 MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2023–2030 (USD MILLION)
TABLE 315 GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 1 SINGLE-CELL SEQUENCING MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
TABLE 3 SINGLE-CELL SEQUENCING MARKET: RISK ASSESSMENT ANALYSIS
TABLE 4 SINGLE-CELL SEQUENCING MARKET: IMPACT ANALYSIS
TABLE 5 SINGLE-CELL SEQUENCING MARKET: RAW MATERIAL VENDORS
TABLE 6 SINGLE-CELL SEQUENCING MARKET: EMERGING BUSINESS MODELS & STRATEGIC ADVANTAGE
TABLE 7 PATENTS APPLIED & GRANTED, 2014–2024
TABLE 8 INNOVATIONS & PATENT REGISTRATIONS, 2024
TABLE 9 IMPORT VALUE OF HS CODE 9027-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020–2024 (USD THOUSANDS)
TABLE 10 IMPORT VOLUME FOR HS CODE 9027-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020–2024 (TONS)
TABLE 11 EXPORT VALUE OF HS CODE 9027-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020–2024 (USD THOUSANDS)
TABLE 12 EXPORT VOLUME FOR HS CODE 9027-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020–2024 (TONS)
TABLE 13 SINGLE-CELL SEQUENCING MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 14 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 15 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18 SINGLE-CELL SEQUENCING MARKET: REGULATORY GUIDELINES
TABLE 19 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYER, 2022–2024
TABLE 20 AVERAGE SELLING PRICE OF PRODUCTS, BY REGION, 2024
TABLE 21 SINGLE-CELL SEQUENCING MARKET: KEY CONFERENCES & EVENTS, 2025–2026
TABLE 22 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR SINGLE-CELL SEQUENCING PRODUCTS
TABLE 23 BUYING CRITERIA FOR SINGLE-CELL SEQUENCING PRODUCTS, BY END USER
TABLE 24 SINGLE-CELL SEQUENCING MARKET: STRATEGIC ANALYSIS OF GROWTH OPPORTUNITIES
TABLE 25 KEY COMPANIES IMPLEMENTING AI IN SINGLE-CELL SEQUENCING MARKET
TABLE 26 KEY PRODUCT-RELATED TARIFF: MISCELLANEOUS CHEMICAL PRODUCTS, ELECTRICAL MACHINERY & EQUIPMENT, AND PARTS THEREOF.
TABLE 27 SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 28 SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 29 NORTH AMERICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 30 EUROPE: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 31 ASIA PACIFIC: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 32 LATIN AMERICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 33 MIDDLE EAST: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 34 GCC COUNTRIES: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 35 SINGLE-CELL SEQUENCING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 36 NORTH AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 37 EUROPE: SINGLE-CELL SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 38 ASIA PACIFIC: SINGLE-CELL SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 39 LATIN AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 40 MIDDLE EAST: SINGLE-CELL SEQUENCING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 41 GCC COUNTRIES: SINGLE-CELL SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 42 SINGLE-CELL SEQUENCING PRODUCT MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 43 SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 44 PRE-SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 45 NORTH AMERICA: PRE-SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 46 EUROPE: PRE-SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 47 ASIA PACIFIC: PRE-SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 48 LATIN AMERICA: PRE-SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 49 MIDDLE EAST: PRE-SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 50 GCC COUNTRIES: PRE-SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 51 SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 52 NORTH AMERICA: SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 53 EUROPE: SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 54 ASIA PACIFIC: SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 55 LATIN AMERICA: SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 56 MIDDLE EAST: SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 57 GCC COUNTRIES: SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 58 SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 59 PRE-SEQUENCING INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 60 NORTH AMERICA: PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 61 EUROPE: PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 62 ASIA PACIFIC: PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 63 LATIN AMERICA: PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 64 MIDDLE EAST: PRE-SEQUENCING INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 65 GCC COUNTRIES: PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 66 PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 67 MICROFLUIDIC INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 68 NORTH AMERICA: MICROFLUIDIC INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 69 EUROPE: MICROFLUIDIC INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 70 ASIA PACIFIC: MICROFLUIDIC INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 71 LATIN AMERICA: MICROFLUIDIC INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 72 MIDDLE EAST: MICROFLUIDIC INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 73 GCC COUNTRIES: MICROFLUIDIC INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 74 CELL SORTERS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 75 NORTH AMERICA: CELL SORTERS MARKET, 2023–2030 (USD MILLION)
TABLE 76 EUROPE: CELL SORTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 77 ASIA PACIFIC: CELL SORTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 78 LATIN AMERICA: CELL SORTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 79 MIDDLE EAST: CELL SORTERS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 80 GCC COUNTRIES: CELL SORTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 81 PCR INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 82 NORTH AMERICA: PCR INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 83 EUROPE: PCR INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 84 ASIA PACIFIC: PCR INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 85 LATIN AMERICA: PCR INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 86 MIDDLE EAST: PCR INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 87 GCC COUNTRIES: PCR INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 88 LCM INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 89 NORTH AMERICA: LCM INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 90 EUROPE: LCM INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 91 ASIA PACIFIC: LCM INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 92 LATIN AMERICA: LCM INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 93 MIDDLE EAST: LCM INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 94 GCC COUNTRIES: LCM INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 95 OTHER PRE-SEQUENCING INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 96 NORTH AMERICA: OTHER PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 97 EUROPE: OTHER PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 98 ASIA PACIFIC: OTHER PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 99 LATIN AMERICA: OTHER PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 100 MIDDLE EAST: OTHER PRE-SEQUENCING INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 101 GCC COUNTRIES: OTHER PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 102 SEQUENCING PLATFORMS MARKET, BY TYPE, 2023–2030 (UNITS)
TABLE 103 SEQUENCING PLATFORMS INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 104 NORTH AMERICA: SEQUENCING PLATFORMS INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 105 EUROPE: SEQUENCING PLATFORMS INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 106 ASIA PACIFIC: SEQUENCING PLATFORMS INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 107 LATIN AMERICA: SEQUENCING PLATFORMS INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 108 MIDDLE EAST: SEQUENCING PLATFORMS INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 109 GCC COUNTRIES: SEQUENCING PLATFORMS INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 110 SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 111 NORTH AMERICA: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 112 EUROPE: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 113 ASIA PACIFIC: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 114 LATIN AMERICA: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 115 MIDDLE EAST: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 116 GCC COUNTRIES: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 117 SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 118 SINGLE-CELL SEQUENCING SOFTWARE TOOLS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 119 NORTH AMERICA: SINGLE-CELL SEQUENCING SOFTWARE TOOLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 120 EUROPE: SINGLE-CELL SEQUENCING SOFTWARE TOOLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 121 ASIA PACIFIC: SINGLE-CELL SEQUENCING SOFTWARE TOOLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 122 LATIN AMERICA: SINGLE-CELL SEQUENCING SOFTWARE TOOLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 123 MIDDLE EAST: SINGLE-CELL SEQUENCING SOFTWARE TOOLS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 124 GCC COUNTRIES: SINGLE-CELL SEQUENCING SOFTWARE TOOLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 125 SINGLE-CELL SEQUENCING DATA STORAGE & MANAGEMENT SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 126 NORTH AMERICA: SINGLE-CELL SEQUENCING DATA STORAGE & MANAGEMENT SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 127 EUROPE: SINGLE-CELL SEQUENCING DATA STORAGE & MANAGEMENT SOFTWARE MARKET, 2023–2030 (USD MILLION)
TABLE 128 ASIA PACIFIC: SINGLE-CELL SEQUENCING DATA STORAGE & MANAGEMENT SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 129 LATIN AMERICA: SINGLE-CELL SEQUENCING DATA STORAGE & MANAGEMENT SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 130 MIDDLE EAST: SINGLE-CELL SEQUENCING DATA STORAGE & MANAGEMENT SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 131 GCC COUNTRIES: SINGLE-CELL SEQUENCING DATA STORAGE & MANAGEMENT SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 132 SINGLE-CELL SEQUENCING PRODUCT MARKET, BY WORKFLOW, 2023–2030 (USD MILLION)
TABLE 133 PRE-SEQUENCING PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 134 NORTH AMERICA: PRE-SEQUENCING PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 135 EUROPE: PRE-SEQUENCING PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 136 ASIA PACIFIC: PRE-SEQUENCING PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 137 LATIN AMERICA: PRE-SEQUENCING PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 138 MIDDLE EAST: PRE-SEQUENCING PRODUCT MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 139 GCC COUNTRIES: PRE-SEQUENCING PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 140 SEQUENCING PRODUCT MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 141 NORTH AMERICA: SEQUENCING PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 142 EUROPE: SEQUENCING PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 143 ASIA PACIFIC: SEQUENCING PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 144 LATIN AMERICA: SEQUENCING PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 145 MIDDLE EAST: SEQUENCING PRODUCT MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 146 GCC COUNTRIES: SEQUENCING PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 147 DATA ANALYSIS & INTERPRETATION PRODUCT MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 148 NORTH AMERICA: DATA ANALYSIS & INTERPRETATION PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 149 EUROPE: DATA ANALYSIS & INTERPRETATION PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 150 ASIA PACIFIC: DATA ANALYSIS & INTERPRETATION PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 151 LATIN AMERICA: DATA ANALYSIS & INTERPRETATION PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 152 MIDDLE EAST: DATA ANALYSIS & INTERPRETATION PRODUCT MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 153 GCC COUNTRIES: DATA ANALYSIS & INTERPRETATION PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 154 SINGLE-CELL SEQUENCING PRODUCT MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 155 SINGLE-CELL SEQUENCING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION)
TABLE 156 NORTH AMERICA: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 157 EUROPE: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 158 ASIA PACIFIC: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 159 LATIN AMERICA: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 160 MIDDLE EAST: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION)
TABLE 161 GCC COUNTRIES: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 162 SINGLE-CELL SEQUENCING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 163 NORTH AMERICA: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 164 EUROPE: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 165 ASIA PACIFIC: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 166 LATIN AMERICA: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 167 MIDDLE EAST: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 168 GCC COUNTRIES: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 169 SINGLE-CELL SEQUENCING PRODUCT MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 170 NORTH AMERICA: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 171 EUROPE: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 172 ASIA PACIFIC: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 173 LATIN AMERICA: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 174 MIDDLE EAST: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 175 GCC COUNTRIES: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 176 SINGLE-CELL SEQUENCING PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2023–2030 (USD MILLION)
TABLE 177 NORTH AMERICA: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 178 EUROPE: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 179 ASIA PACIFIC: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 180 LATIN AMERICA: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 181 MIDDLE EAST: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2023–2030 (USD MILLION)
TABLE 182 GCC COUNTRIES: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 183 SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 184 PRE-SEQUENCING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 185 NORTH AMERICA: PRE-SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 186 EUROPE: PRE-SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 187 ASIA PACIFIC: PRE-SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 188 LATIN AMERICA: PRE-SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 189 MIDDLE EAST: PRE-SEQUENCING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 190 GCC COUNTRIES: PRE-SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 191 PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 192 SAMPLE PREPARATION, SINGLE-CELL ISOLATION, AND ENRICHMENT SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 193 NORTH AMERICA: SAMPLE PREPARATION, SINGLE-CELL ISOLATION, AND ENRICHMENT SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 194 EUROPE: SAMPLE PREPARATION, SINGLE-CELL ISOLATION, AND ENRICHMENT SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 195 ASIA PACIFIC: SAMPLE PREPARATION, SINGLE-CELL ISOLATION, AND ENRICHMENT SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 196 LATIN AMERICA: SAMPLE PREPARATION, SINGLE-CELL ISOLATION, AND ENRICHMENT SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 197 MIDDLE EAST: SAMPLE PREPARATION, SINGLE-CELL ISOLATION, AND ENRICHMENT SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 198 GCC COUNTRIES: SAMPLE PREPARATION, SINGLE-CELL ISOLATION, AND ENRICHMENT SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 199 LIBRARY PREPARATION SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 200 NORTH AMERICA: LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 201 EUROPE: LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 202 ASIA PACIFIC: LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 203 LATIN AMERICA: LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 204 MIDDLE EAST: LIBRARY PREPARATION SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 205 GCC COUNTRIES: LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 206 SEQUENCING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 207 NORTH AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 208 EUROPE: SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 209 ASIA PACIFIC: SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 210 LATIN AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 211 MIDDLE EAST: SEQUENCING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 212 GCC COUNTRIES: SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 213 DATA ANALYSIS & BIOINFORMATICS SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 214 NORTH AMERICA: DATA ANALYSIS & BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 215 EUROPE: DATA ANALYSIS & BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 216 ASIA PACIFIC: DATA ANALYSIS & BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 217 LATIN AMERICA: DATA ANALYSIS & BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 218 MIDDLE EAST: DATA ANALYSIS & BIOINFORMATICS SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 219 GCC COUNTRIES: DATA ANALYSIS & BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 220 SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 221 SINGLE-CELL SEQUENCING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION)
TABLE 222 NORTH AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 223 EUROPE: SINGLE-CELL SEQUENCING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 224 ASIA PACIFIC: SINGLE-CELL SEQUENCING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 225 LATIN AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 226 MIDDLE EAST: SINGLE-CELL SEQUENCING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION)
TABLE 227 GCC COUNTRIES: SINGLE-CELL SEQUENCING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 228 SINGLE-CELL SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 229 NORTH AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 230 EUROPE: SINGLE-CELL SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 231 ASIA PACIFIC: SINGLE-CELL SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 232 LATIN AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 233 MIDDLE EAST: SINGLE-CELL SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 234 GCC COUNTRIES: SINGLE-CELL SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 235 SINGLE-CELL SEQUENCING SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 236 NORTH AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 237 EUROPE: SINGLE-CELL SEQUENCING SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 238 ASIA PACIFIC: SINGLE-CELL SEQUENCING SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 239 LATIN AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 240 MIDDLE EAST: SINGLE-CELL SEQUENCING SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 241 GCC COUNTRIES: SINGLE-CELL SEQUENCING SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 242 SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION)
TABLE 243 SINGLE-CELL TRANSCRIPTOME SEQUENCING MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 244 NORTH AMERICA: SINGLE-CELL TRANSCRIPTOME SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 245 EUROPE: SINGLE-CELL TRANSCRIPTOME SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 246 ASIA PACIFIC: SINGLE-CELL TRANSCRIPTOME SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 247 LATIN AMERICA: SINGLE-CELL TRANSCRIPTOME SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 248 MIDDLE EAST: SINGLE-CELL TRANSCRIPTOME SEQUENCING MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 249 GCC COUNTRIES: SINGLE-CELL TRANSCRIPTOME SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 250 SINGLE-CELL GENOME SEQUENCING MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 251 NORTH AMERICA: SINGLE-CELL GENOME SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 252 EUROPE: SINGLE-CELL GENOME SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 253 ASIA PACIFIC: SINGLE-CELL GENOME SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 254 LATIN AMERICA: SINGLE-CELL GENOME SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 255 MIDDLE EAST: SINGLE-CELL GENOME SEQUENCING MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 256 GCC COUNTRIES: SINGLE-CELL GENOME SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 257 SINGLE-CELL ATAC SEQUENCING MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 258 NORTH AMERICA: SINGLE-CELL ATAC SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 259 EUROPE: SINGLE-CELL ATAC SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 260 ASIA PACIFIC: SINGLE-CELL ATAC SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 261 LATIN AMERICA: SINGLE-CELL ATAC SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 262 MIDDLE EAST: SINGLE-CELL ATAC SEQUENCING MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 263 GCC COUNTRIES: SINGLE-CELL ATAC SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 264 OTHER SINGLE-CELL SEQUENCING TYPES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 265 NORTH AMERICA: OTHER SINGLE-CELL SEQUENCING TYPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 266 EUROPE: OTHER SINGLE-CELL SEQUENCING TYPES MARKET, 2023–2030 (USD MILLION)
TABLE 267 ASIA PACIFIC: OTHER SINGLE-CELL SEQUENCING TYPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 268 LATIN AMERICA: OTHER SINGLE-CELL SEQUENCING TYPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 269 MIDDLE EAST: OTHER SINGLE-CELL SEQUENCING TYPES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 270 GCC COUNTRIES: OTHER SINGLE-CELL SEQUENCING TYPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 271 SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 272 SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 273 SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATIONAL RESEARCH, BY TYPE, 2023–2030 (USD MILLION)
TABLE 274 SINGLE-CELL SEQUENCING MARKET FOR CANCER RESEARCH, BY REGION, 2023–2030 (USD MILLION)
TABLE 275 NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 276 EUROPE: SINGLE-CELL SEQUENCING MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 277 ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 278 LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 279 MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR CANCER RESEARCH, BY REGION, 2023–2030 (USD MILLION)
TABLE 280 GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 281 SINGLE-CELL SEQUENCING MARKET FOR STEM CELL & DEVELOPMENTAL BIOLOGY, BY REGION, 2023–2030 (USD MILLION)
TABLE 282 NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET FOR STEM CELL & DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 283 EUROPE: SINGLE-CELL SEQUENCING MARKET FOR STEM CELL & DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 284 ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR STEM CELL & DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 285 LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR STEM CELL & DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 286 MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR STEM CELL & DEVELOPMENTAL BIOLOGY, BY REGION, 2023–2030 (USD MILLION)
TABLE 287 GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR STEM CELL & DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 288 SINGLE-CELL SEQUENCING MARKET FOR NEUROLOGY & BRAIN RESEARCH, BY REGION, 2023–2030 (USD MILLION)
TABLE 289 NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET FOR NEUROLOGY & BRAIN RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 290 EUROPE: SINGLE-CELL SEQUENCING MARKET FOR NEUROLOGY & BRAIN RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 291 ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR NEUROLOGY & BRAIN RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 292 LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR NEUROLOGY & BRAIN RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 293 MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR NEUROLOGY & BRAIN RESEARCH, BY REGION, 2023–2030 (USD MILLION)
TABLE 294 GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR NEUROLOGY & BRAIN RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 295 SINGLE-CELL SEQUENCING MARKET FOR MICROBIOLOGY & INFECTIOUS DISEASES, BY REGION, 2023–2030 (USD MILLION)
TABLE 296 NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET FOR MICROBIOLOGY & INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 297 EUROPE: SINGLE-CELL SEQUENCING MARKET FOR MICROBIOLOGY & INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 298 ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR MICROBIOLOGY & INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 299 LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR MICROBIOLOGY & INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 300 MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR MICROBIOLOGY & INFECTIOUS DISEASES, BY REGION, 2023–2030 (USD MILLION)
TABLE 301 GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR MICROBIOLOGY & INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 302 SINGLE-CELL SEQUENCING MARKET FOR ORGAN DEVELOPMENT & REGENERATIVE MEDICINE, BY REGION, 2023–2030 (USD MILLION)
TABLE 303 NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET FOR ORGAN DEVELOPMENT & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 304 EUROPE: SINGLE-CELL SEQUENCING MARKET FOR ORGAN DEVELOPMENT & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 305 ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR ORGAN DEVELOPMENT & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 306 LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR ORGAN DEVELOPMENT & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 307 MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR ORGAN DEVELOPMENT & REGENERATIVE MEDICINE, BY REGION, 2023–2030 (USD MILLION)
TABLE 308 GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR ORGAN DEVELOPMENT & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 309 SINGLE-CELL SEQUENCING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2023–2030 (USD MILLION)
TABLE 310 NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 311 EUROPE: SINGLE-CELL SEQUENCING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 312 ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 313 LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 314 MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2023–2030 (USD MILLION)
TABLE 315 GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
LIST OF FIGURES
FIGURE 1 SINGLE-CELL SEQUENCING MARKET: MARKETS & REGIONS COVERED
FIGURE 2 REGIONAL SEGMENTATION
FIGURE 3 YEARS CONSIDERED
FIGURE 4 RESEARCH DESIGN METHODOLOGY
FIGURE 5 SINGLE-CELL SEQUENCING MARKET: BREAKDOWN OF PRIMARY INTERVIEWS
FIGURE 6 SINGLE-CELL SEQUENCING MARKET SIZE ESTIMATION, 2024
FIGURE 7 GLOBAL MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH), 2024
FIGURE 8 ILLUSTRATIVE EXAMPLE OF 10X GENOMICS: REVENUE ANALYSIS (2024)
FIGURE 9 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
FIGURE 10 SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
FIGURE 11 SINGLE-CELL SEQUENCING MARKET: CAGR PROJECTIONS, 2025?2030
FIGURE 12 SINGLE-CELL SEQUENCING MARKET: GROWTH ANALYSIS OF MARKET DYNAMICS
FIGURE 13 DATA TRIANGULATION METHODOLOGY
FIGURE 14 SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2025 VS. 2030 (USD MILLION)
FIGURE 15 SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 16 SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2024
FIGURE 17 SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 18 SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
FIGURE 19 SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 20 SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
FIGURE 21 SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
FIGURE 22 GEOGRAPHIC SNAPSHOT OF SINGLE-CELL SEQUENCING MARKET
FIGURE 23 ADVANCEMENTS IN SINGLE-CELL SEQUENCING TECHNOLOGIES TO PROPEL MARKET
FIGURE 24 PRODUCTS SEGMENT IN US ACCOUNTED FOR LARGEST MARKET SHARE IN 2024
FIGURE 25 CANCER RESEARCH APPLICATIONS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2024
FIGURE 26 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2024
FIGURE 27 BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2024
FIGURE 28 ASIA PACIFIC REGION TO DOMINATE MARKET DURING FORECAST PERIOD
FIGURE 29 SINGLE-CELL SEQUENCING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 30 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 31 SINGLE-CELL SEQUENCING MARKET: VALUE CHAIN ANALYSIS
FIGURE 32 SINGLE-CELL SEQUENCING MARKET: ECOSYSTEM ANALYSIS
FIGURE 33 PATENT APPLICATIONS IN SINGLE-CELL SEQUENCING MARKET, JANUARY 2014–DECEMBER 2024
FIGURE 34 SINGLE-CELL SEQUENCING MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 35 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYER, 2022–2024
FIGURE 36 AVERAGE SELLING PRICE OF PRODUCTS, BY REGION, 2024
FIGURE 37 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR SINGLE-CELL SEQUENCING PRODUCTS
FIGURE 38 KEY BUYING CRITERIA FOR END USERS
FIGURE 39 AI-USE CASES
FIGURE 40 NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET SNAPSHOT
FIGURE 41 NIH FUNDING FOR STEM CELL RESEARCH, 2015–2025
FIGURE 42 ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET SNAPSHOT
FIGURE 43 REVENUE ANALYSIS OF KEY PLAYERS IN SINGLE-CELL SEQUENCING MARKET, 2022–2024
FIGURE 44 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024
FIGURE 45 SINGLE-CELL SEQUENCING PRODUCTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 46 SINGLE-CELL SEQUENCING PRODUCT MARKET: COMPANY FOOTPRINT
FIGURE 47 SINGLE-CELL SEQUENCING SERVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 48 SINGLE-CELL SEQUENCING SERVICES MARKET: COMPANY FOOTPRINT
FIGURE 49 SINGLE-CELL SEQUENCING MARKET: COMPANY EVALUATION MATRIX, (STARTUPS/SMES), 2024
FIGURE 50 EV/EBITDA OF KEY VENDORS
FIGURE 51 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 52 SINGLE-CELL SEQUENCING MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 53 BD: COMPANY SNAPSHOT (2024)
FIGURE 54 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)
FIGURE 55 DANAHER CORPORATION: COMPANY SNAPSHOT (2024)
FIGURE 56 10X GENOMICS: COMPANY SNAPSHOT (2024)
FIGURE 57 ILLUMINA, INC.: COMPANY SNAPSHOT (2024)
FIGURE 58 MERCK KGAA: COMPANY SNAPSHOT (2024)
FIGURE 59 QIAGEN N.V.: COMPANY SNAPSHOT (2024)
FIGURE 60 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024)
FIGURE 61 TECAN TRADING AG: COMPANY SNAPSHOT (2024)
FIGURE 62 CYTEK BIOSCIENCES: COMPANY SNAPSHOT (2024)
FIGURE 63 TAKARA BIO INC.: COMPANY SNAPSHOT (2024)
FIGURE 66 AZENTA US INC.: COMPANY SNAPSHOT (2024)
FIGURE 67 IQVIA INC.: COMPANY SNAPSHOT (2024)
FIGURE 1 SINGLE-CELL SEQUENCING MARKET: MARKETS & REGIONS COVERED
FIGURE 2 REGIONAL SEGMENTATION
FIGURE 3 YEARS CONSIDERED
FIGURE 4 RESEARCH DESIGN METHODOLOGY
FIGURE 5 SINGLE-CELL SEQUENCING MARKET: BREAKDOWN OF PRIMARY INTERVIEWS
FIGURE 6 SINGLE-CELL SEQUENCING MARKET SIZE ESTIMATION, 2024
FIGURE 7 GLOBAL MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH), 2024
FIGURE 8 ILLUSTRATIVE EXAMPLE OF 10X GENOMICS: REVENUE ANALYSIS (2024)
FIGURE 9 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
FIGURE 10 SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
FIGURE 11 SINGLE-CELL SEQUENCING MARKET: CAGR PROJECTIONS, 2025?2030
FIGURE 12 SINGLE-CELL SEQUENCING MARKET: GROWTH ANALYSIS OF MARKET DYNAMICS
FIGURE 13 DATA TRIANGULATION METHODOLOGY
FIGURE 14 SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2025 VS. 2030 (USD MILLION)
FIGURE 15 SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 16 SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2024
FIGURE 17 SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 18 SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
FIGURE 19 SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 20 SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
FIGURE 21 SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
FIGURE 22 GEOGRAPHIC SNAPSHOT OF SINGLE-CELL SEQUENCING MARKET
FIGURE 23 ADVANCEMENTS IN SINGLE-CELL SEQUENCING TECHNOLOGIES TO PROPEL MARKET
FIGURE 24 PRODUCTS SEGMENT IN US ACCOUNTED FOR LARGEST MARKET SHARE IN 2024
FIGURE 25 CANCER RESEARCH APPLICATIONS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2024
FIGURE 26 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2024
FIGURE 27 BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2024
FIGURE 28 ASIA PACIFIC REGION TO DOMINATE MARKET DURING FORECAST PERIOD
FIGURE 29 SINGLE-CELL SEQUENCING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 30 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 31 SINGLE-CELL SEQUENCING MARKET: VALUE CHAIN ANALYSIS
FIGURE 32 SINGLE-CELL SEQUENCING MARKET: ECOSYSTEM ANALYSIS
FIGURE 33 PATENT APPLICATIONS IN SINGLE-CELL SEQUENCING MARKET, JANUARY 2014–DECEMBER 2024
FIGURE 34 SINGLE-CELL SEQUENCING MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 35 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYER, 2022–2024
FIGURE 36 AVERAGE SELLING PRICE OF PRODUCTS, BY REGION, 2024
FIGURE 37 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR SINGLE-CELL SEQUENCING PRODUCTS
FIGURE 38 KEY BUYING CRITERIA FOR END USERS
FIGURE 39 AI-USE CASES
FIGURE 40 NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET SNAPSHOT
FIGURE 41 NIH FUNDING FOR STEM CELL RESEARCH, 2015–2025
FIGURE 42 ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET SNAPSHOT
FIGURE 43 REVENUE ANALYSIS OF KEY PLAYERS IN SINGLE-CELL SEQUENCING MARKET, 2022–2024
FIGURE 44 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024
FIGURE 45 SINGLE-CELL SEQUENCING PRODUCTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 46 SINGLE-CELL SEQUENCING PRODUCT MARKET: COMPANY FOOTPRINT
FIGURE 47 SINGLE-CELL SEQUENCING SERVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 48 SINGLE-CELL SEQUENCING SERVICES MARKET: COMPANY FOOTPRINT
FIGURE 49 SINGLE-CELL SEQUENCING MARKET: COMPANY EVALUATION MATRIX, (STARTUPS/SMES), 2024
FIGURE 50 EV/EBITDA OF KEY VENDORS
FIGURE 51 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 52 SINGLE-CELL SEQUENCING MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 53 BD: COMPANY SNAPSHOT (2024)
FIGURE 54 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)
FIGURE 55 DANAHER CORPORATION: COMPANY SNAPSHOT (2024)
FIGURE 56 10X GENOMICS: COMPANY SNAPSHOT (2024)
FIGURE 57 ILLUMINA, INC.: COMPANY SNAPSHOT (2024)
FIGURE 58 MERCK KGAA: COMPANY SNAPSHOT (2024)
FIGURE 59 QIAGEN N.V.: COMPANY SNAPSHOT (2024)
FIGURE 60 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024)
FIGURE 61 TECAN TRADING AG: COMPANY SNAPSHOT (2024)
FIGURE 62 CYTEK BIOSCIENCES: COMPANY SNAPSHOT (2024)
FIGURE 63 TAKARA BIO INC.: COMPANY SNAPSHOT (2024)
FIGURE 66 AZENTA US INC.: COMPANY SNAPSHOT (2024)
FIGURE 67 IQVIA INC.: COMPANY SNAPSHOT (2024)
